Gene Activation by Varicella-Zoster Virus IE4 Protein Requires
Its Dimerization and Involves Both the Arginine-rich Sequence, the
Central Part, and the Carboxyl-terminal Cysteine-rich Region*
Laurence
Baudoux
,
Patricia
Defechereux§,
Bernard
Rentier, and
Jacques
Piette¶
From the Laboratory of Fundamental Virology and Immunology,
Institute of Pathology B23, University of Liege,
B-4000 Liege, Belgium
Received for publication, February 22, 2000, and in revised form, July 7, 2000
 |
ABSTRACT |
Varicella-zoster virus (VZV) open reading frame
4-encoded protein (IE4) possesses transactivating properties for VZV
genes as well as for those of heterologous viruses. Since most
transcription factors act as dimers, IE4 dimerization was studied using
the mammalian two-hybrid system. Introduction of mutations in the IE4
open reading frame demonstrated that both the central region and the
carboxyl-terminal cysteine-rich domain were important for efficient
dimerization. Within the carboxyl-terminal domain, substitution of
amino acids encompassing residues 443-447 totally abolished
dimerization. Gene activation by IE4 was studied by transient
transfection with an IE4 expression plasmid and a reporter gene under
the control of either the human immunodeficiency virus, type 1, long
terminal repeat or the VZV thymidine kinase promoter. Regions of IE4
important for dimerization were also shown to be crucial for
transactivation. In addition, the arginine-rich domains Rb and Rc of
the amino-terminal region were also demonstrated to be important for
transactivation, whereas the Ra domain as well as an acidic and
bZIP-containing regions were shown to be dispensable for gene
transactivation. A nucleocytoplasmic shuttling of IE4 has also been
characterized, involving a nuclear localization signal identified
within the Rb domain and a nuclear export mechanism partially depending
on Crm-1.
 |
INTRODUCTION |
Varicella-zoster virus
(VZV)1 is an
-herpesvirus
that causes two distinct diseases in man, chicken pox and shingles.
Shortly after entry into the cells, VZV genes are expressed in a
temporal cascade. The immediate-early genes are expressed first; these stimulate early gene expression, providing most of the proteins necessary for viral DNA replication. After DNA synthesis has occurred, genes of the late class, which mainly encode structural proteins, are
expressed. This orderly pattern of expression has been proposed mainly
by comparison with herpes simplex virus, type 1 (HSV-1) (1), another
-herpesvirus that has been intensively studied. The use of transient
transfection assays has clearly shown that several VZV proteins,
i.e. those encoded by open reading frames 4, 10, 29, 61, 62, and 63, possess regulatory properties (2-8). Three of these
polypeptides, encoded by open reading frames 4, 62, and 63, are
expressed during the immediate-early phase of lytic infection (9-11)
and are thus referred to as IE4, IE62, and IE63. Therefore, VZV
immediate-early proteins contribute to the control of the viral cycle
progression as in other
-herpesviruses.
The IE4 protein is a transactivator of gene expression whose regulatory
properties are not yet fully understood (2, 4, 11-14). IE4 stimulates
VZV gene expression regardless of the cell type envisaged,
i.e. monkey fibroblasts or human T lymphocytes (2, 4, 11,
12). It also appears that IE4 is capable of heterologous
transactivation (11-13). The available data suggest that IE4 could
exert its functions through transcriptional and post-transcriptional
mechanisms (11-13). VZV IE4 is a 452-amino acid long protein that
shares considerable amino acid sequence homology with HSV-1 IE protein
ICP27, especially in the carboxyl terminus and in the central part of
the protein (13, 15). The carboxyl-terminal region of ICP27 that is
rich in cysteine and histidine residues has been shown to bind zinc
(16) and be required for multimerization (17). Whereas the
carboxyl-terminal region of IE4 also contains cysteine and histidine
residues, it is not known whether this region also binds zinc nor
whether it forms a potential zinc finger domain. A rather large part of
ICP-27 spanning amino acids 260-434 was shown to be critical for gene activation (18, 19). Mutations in this activation domain exhibited a
transdominant negative phenotype (18). The amino-terminal regions of
these two proteins have a more limited amino acid homology; however,
both are highly acidic (14). Sixteen of the first 66 amino acids of the
amino-terminal region of VZV IE4 are either aspartic or glutamic acid,
and seven residues are serine which, if phosphorylated, may be
negatively charged. Net acidity is characteristic of several
transcriptional activators; however, other critical structural features
are also required for transactivating activity (for review, see Ref.
20). Close to the amino-terminal region, ICP27 possesses a sequence
that resembles an RGG box, an RNA-binding motif found in a number of
cellular proteins involved in mRNA and rRNA metabolism. The RGG box
sequence is composed of 15 consecutive arginine and glycine residues
and is required for ICP27 nucleolar localization, possibly reflecting
an in vivo RNA binding activity (19-22). VZV IE4 does not
bear an RGG box but instead has three arginine-rich regions (Ra, Rb,
and Rc) and three potential bZIP sequences that are fused to the
amino-terminal side of the Rb region. The function of these repeats is
still unknown. ICP27 contains multiple nuclear localization signals
(NLS) that function with differing efficiencies. A strong NLS maps to
residues 110-137; it bears similarity to the bipartite NLS found in
Xenopus laevis nucleoplasmin. Weak NLS(s) map to the central
and/or carboxyl-terminal portion of the protein (22). No equivalent to
this strong NLS has been yet found in VZV IE4. However, area
encompassing the putative bZIP domain shares some homology with the NLS
of the HIV-1 Tat protein. Recently, ICP27 has been shown to shuttle
between the nucleus and cytoplasm through a leucine-rich nuclear export signal in the amino terminus (23, 25). Since it has been demonstrated that ICP27 can bind seven intronless HSV-1 transcripts and that the
export of these transcripts to the cytoplasm is substantially reduced
during infection with 27-LacZ virus, where ICP27 is not expressed, it
may be suggested that export of intronless mRNAs by ICP27 comprises
at least part of its function as an essential regulator of viral gene
expression. Whereas VZV IE4 exhibits a main cytoplasmic localization,
no potential NES site can be located within its amino-terminal portion.
The purpose of this report was to clarify the molecular mechanisms of
IE4-mediated gene activation. Our results indicate that IE4
homodimerization mainly occurred through the central and the carboxyl-terminal region of the protein. Amino acid substitution within
the carboxyl-terminal domain showed that a GKYFKC peptide was crucial
for dimerization. Regions of IE4 important for dimerization were also
shown to be necessary for transactivation. In addition, the
arginine-rich domains Rb and Rc of the amino-terminal region of IE4
were also demonstrated to be important for transactivation, whereas the
first Ra domain as well as an acidic and bZIP-containing regions were
shown to be dispensable for gene transactivation. A nucleocytoplasmic
shuttling of IE4 has also been characterized. It likely involved a
nuclear localization signal identified within the Rb domain. In
addition, we demonstrated that IE4 shuttled between the nucleus and the
cytoplasm partly via a Crm1-dependent mechanism. Both the
central and carboxyl-terminal regions are involved in the nuclear
export of IE4.
 |
MATERIALS AND METHODS |
Cells and Transfections--
The HeLa human cervical epithelioid
carcinoma cell line was grown in Dulbecco's modified Eagle's medium
supplemented with 10% fetal calf serum. Transfections were carried out
on cells seeded into 35-mm diameter six-well cluster dishes using the
FUGENE 6 reagent (Roche Molecular Biochemicals). To determine CAT
activities, whole-cell extracts were prepared by the freeze-thaw method
as described previously (12). LUC assays were performed using the "Luciferase Reporter Gene Assay, high sensitivity" kit (Roche Molecular Biochemicals), according to the instructions of the manufacturer. Data from CAT and LUC assays were collected from at least
four independent transfection experiments.
Plasmids--
Plasmids pHIV-1-CAT and pTK-CAT were described
previously (12, 26). In these constructs, the wild-type LTR of HIV-1 or the VZV thymidine kinase gene promoter, respectively, is cloned upstream of the CAT gene. The reporter construct
p(gal4)5SV40-LUC was a gift from Dr. M. Müller
(University of Liege, Belgium) and contained the LUC reporter gene
under the control of five copies of the Gal4 DNA-binding sites upstream
of the SV40 promoter.
Plasmids pM and pVP16 (CLONTECH) harbored the SV40
promoter driving the Gal4 DNA-binding domain or the HSV-1 VP16
activation domain, respectively. The constructs pM4 and pVP16-IE4 were
made by insertion of the IE4 gene into the
EcoRI site of pM or pVP16 in frame with the Gal4 DNA-binding
domain or the HSV-1 VP16 activation domain coding sequence,
respectively. The IE4 coding sequence was amplified by PCR using
oligonucleotides carrying an EcoRI site at 5'.
Base substitutions or deletion into the IE4 gene were
generated by PCR using mismatching primers that created a new
restriction site in the vector. The PCR mixture consisted of 25 mM KCl, 10 mM Tris-HCl (pH 8.8), 5 mM (NH4)2SO4, 2 mM MgSO4, 0.8 mM dNTP mix, 2.5 units of Pwo DNA polymerase (Roche Molecular Biochemicals), 1 µM each primer, and 200 ng of pM4 in a total volume of
100 µl. The amplification procedure started with a 2-min preheating
step at 94 °C followed by 35 cycles, each consisting of a 94 °C
denaturation segment for 15 s, a 50-60 °C annealing segment
for 30 s (depending on the set of primers used), and a 72 °C
extension segment for 4 min; the whole set was followed by a final
extension at 72 °C for 7 min. After amplification, the PCR products
were resolved on a 0.8% agarose gel electrophoresis, and the fragment
corresponding to the size of the linearized vector was recovered using
the Bio-Rad gel extraction kit (Bio-Rad). After phosphorylation of the
5'-end of the fragment with the T4 polynucleotide kinase (Roche
Molecular Biochemicals), the plasmid was recircularized by the T4 DNA
ligase (Roche Molecular Biochemicals), transformed into
Escherichia coli DH5
, and then analyzed for the presence
of the new restriction sites introduced during the PCR. By this
procedure, plasmids harboring mutations in the carboxyl-terminal region
of IE4 were obtained as follows: pM4-G442, -K443, -Y444, -FK445, -C447,
-ST448, -FN450, and -C452 (the numbers refer to the position of the
mutation in relation to the first methionine residue of the IE4
protein). Substitutions within the amino-terminal region of IE4 were
also created by PCR. These plasmids were named pM4-Rb, pM4-Rc, pM4-Rb + Rc, pM4-bZIP, pM4-bZIP + Rb + Rc. The corresponding mutations are
detailed in Fig. 4. Deletion mutants in the IE4 gene
were obtained by a similar procedure: pM4-D-(1-65), pM4-D-(66-110), pM4-D-(111-181), pM4-D-(111-150), pM4-D-(150-182), pM4-D-(183-390), pM4-D-(182-231), pM4-D-(266-302), pM4-D-(314-385), pM4-D-(403-452), pM4-D-(427-452), and pM4-D-(444-452); the positions of the deleted amino acids are indicated in parentheses.
To create pC4 wt and mutated, the wild-type IE4 sequence as well as
both mutated sequences were excised from pM4 wt or mutated by digestion
with EcoRI. The 1359-base pair fragments were then cloned
into the polycloning site of pCDNA3.1.
(Invitrogen,
Inc., Leek, The Netherlands) under the control of the cytomegalovirus
promoter-enhancer or the T7 promoter. The nomenclature used for the
description of these mutated pC4 plasmids was the same as detailed above.
Immunofluorescence--
HeLa cells seeded into 10-mm dishes were
transfected with 2 µg of pC4 or its derivatives using the FUGENE 6 reagent (Roche Molecular Biochemicals). To perform immunofluorescence
studies, transfected cells grown on coverslips were treated as
described previously (27). In order to detect wild-type IE4 or mutated forms, a rabbit polyclonal antiserum that was raised against a GST-IE4
fusion protein was prepared and used as described (10). In some
experiments, leptomycin B (LMB, provided by B. Wolff, Novartis, Vienna,
Austria) was added to the culture medium 48 h post-transfection at
a concentration of 10 nM. Six hours later, cells were fixed
and treated for indirect immunofluorescence.
In Vitro Analysis of Protein-Protein Interactions--
The
various constructs (GST, GST-TK, GST-p50, and GST-TFIIB (29)) were
expressed in E. coli following classical induction with 0.1 mM isopropyl-1-thio-
-D-galactopyranoside for
3 h at 37 °C. Lysates were prepared as described (29), and
proteins were then purified on glutathione-Sepharose 4B affinity beads (Amersham Pharmacia Biotech) in phosphate-buffered saline/Triton 1%
(v/v), following extensive washing in phosphate-buffered saline. IE4
proteins were expressed from pC4 and its derivatives and labeled with
[35S]methionine (ICN, Brussels, Belgium) using the
in vitro TNT-T7-coupled reticulocyte lysate system (Promega
Inc., Madison, WI). 5 µl of 35S-labeled proteins were
incubated with 30 µl of protein-coupled Sepharose beads in 400 µl
of NETN (20 mM Tris-HCl (pH 8), 100 mM NaCl, 1 mM EDTA, 1.5% (v/v) Nonidet P-40). Binding reactions were
allowed to take place for 3 h at 4 °C, and the beads were then
washed six times in NETN. Bound proteins were eluated by boiling for 2 min in 1× SDS sample buffer, followed by loading on 10% SDS-PAGE.
Gels were subsequently dried and autoradiographed.
 |
RESULTS |
IE4 Homodimerization Is Required for Transactivation--
Since we
previously showed that IE4-activated gene expression under the
control of the HIV-1 LTR through interactions with members of the
NF-
B family and factors of the basal transcription machinery (29),
we decided to investigate whether gene activation by IE4 requires its
homodimerization. Therefore, to study IE4 dimerization, we used a
mammalian two-hybrid system (30) based on the construction of two
chimeric proteins between IE4 and either the Gal4 DNA-binding domain or
the VP16 activation domain. The unmodified vectors or each of the
individual fusion genes displayed low background LUC activity when
co-transfected with reporter plasmid p(gal4)5SV40-LUC
into HeLa cells, whereas transfection with a combination of plasmids
encoding IE4-Gal4 DNA-binding and IE4-VP16 fusion proteins (pM4 and
pVP16-IE4) resulted in a 32-fold increase in LUC gene expression (Fig.
1). These data indicate that IE4
homodimerization is readily detectable in mammalian cells and is
required for gene transactivation of an artificial construct.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
IE4 homodimerization in the mammalian
two-hybrid system. HeLa cells were co-transfected with 1 µg of
the reporter plasmid p(gal4)5SV40-LUC and 2 µg of pM or 2 µg of pM4 together with 2 µg of pVP16 or pVP16-IE4 as indicated.
LUC assays were carried out 48 h post-transfection. Fold
stimulation of LUC activity was calculated relative to the basal level
of the reporter plasmid in the presence of pM and pVP16, arbitrarily
set to 1. Data from four independent experiments are shown with
standard errors of the means.
|
|
The Central and Carboxyl-terminal Regions of IE4 Are Important for
Homodimerization--
In order to delineate the regions of IE4 that
are important for dimerization, we first introduced deletions into the
IE4 gene fused to the Gal4 DNA-binding domain (Fig.
2). Deletion of either the acidic domain
(Fig. 2, pM4-D-(1-65)) or the first arginine-rich region
(Ra) (Fig. 2, pM4-D-(66-110)) within the amino-terminal region did not affect homodimerization. Individual deletion of the
arginine-rich regions b (Rb) and c (Rc) only partially affected homodimerization (Fig. 2, pM4-D-(111-150) and
pM4-D-(150-182)), whereas the removal of both Rb and Rc
decreased homodimerization by about 75% (Fig. 2,
pM4-D-(111-181)). It should be noted that this deletion was
rather large and removed 70 amino acids. On the other hand, deletion of
the central region of IE4 comprised between amino acids 182 and 385 yielded an important reduction of homodimerization (about 90%
reduction) (Fig. 2, pM4-D-(183-390)). Smaller deletions
(between 49 and 71 amino acids into pM4-D-(182-231), -D-(266-302),
and -D-(314-385)) were introduced within the central domain, and all
led to a complete loss of homodimerization. Reintroduction of a
irrelevant VZV sequence within the deleted IE4 gene
(pM4-D- ()) did not allow recovery of efficient
homodimerization (data not shown), demonstrating that the central
region of IE4 itself is involved in the homodimerization process.
Deletions within the cysteine-rich domain of IE4 demonstrated that the
carboxyl-terminal region is important for homodimerization (Fig. 2,
pM4-D-(403-452)). Indeed, deletion of either the complete
cysteine-rich region (amino acids 393-452) or part of it (amino acids
444-452) drastically reduced homodimerization, demonstrating that the
carboxyl-terminal regions of IE4 is also important for
homodimerization.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 2.
Homodimerization properties of IE4 deletion
mutants. A schematic representation of the 452-amino acid coding
region of IE4 is illustrated. The acidic (Acid) and the
arginine-rich regions (Ra, Rb, and Rc), as well
as the central part (Central) and the cysteine-rich
carboxyl-terminal domain (Cys) are shown. The fusion
constructs used to measure IE4 homodimerization are depicted with the
Gal4 DNA-binding domain fused to various deleted IE4 proteins
(lines and dotted lines). The deleted amino acids
are represented by dotted lines and are indicated in
parentheses. HeLa cells were co-transfected with 1 µg of
p(gal4)5SV40-LUC, 2 µg of pVP16-IE4, and 2 µg of the
various constructs as indicated. Fold stimulation of LUC activity was
calculated relative to the basal level of reporter plasmid in the
presence of pM and pVP16-IE4, arbitrarily set to 1. Results from at
least four independent experiments are presented with standard errors
of the means.
|
|
The GKYFKC Sequence within the Carboxyl-terminal Region Is Crucial
for Homodimerization--
Since the carboxyl-terminal region of IE4 is
rather conserved among
-herpesviruses (Fig.
3A), we decided to substitute
several amino acids comprised between residues 442 and 452 (Fig.
3B). As mentioned above, deletion of the last 10 amino acids
led to a 90% drop in LUC activity (Fig. 3B,
pM4-D-(444-452)). Mutation of the Gly-442 reduced
homodimerization to about 30% of the initial value, and either single
or double substitution within the KYFKC sequence completely abolished
its activity. On the other hand, substitution of the last five amino
acids (from 448 to 452) did not affect reporter gene stimulation (Fig.
3B), showing that the hexapeptide GKYFKC within the
carboxyl-terminal region played an essential role in IE4
homodimerization.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Role of the carboxyl-terminal region of IE4
in homodimerization. A, alignment of the amino acids
within the carboxyl-terminal region of IE4 with the corresponding
regions found in other -herpesvirus homologs (ICP27 from HSV-1 and
UL3 from EHV-1). Numbers indicate the boundaries of the
sequences in the context of the native proteins. B, relative
homodimerization activity of the Gal4-IE4 mutants bearing various amino
acid substitutions. The boldface letters indicate amino acid
substitutions. HeLa cells were co-transfected with 1 µg of
p(gal4)5SV40-LUC, 2 µg of pVP16-IE4, and 2 µg of the
various fusion Gal4 constructs as indicated. Fold stimulation of LUC
activity was calculated relative to the basal level of the reporter
plasmid in the presence of pM and pVP16-IE4, arbitrarily set to 1. Results from at least four independent experiments are shown with
standard errors of the means.
|
|
Arginine-rich Repeats Rb and Rc Are Not Essential for IE4
Homodimerization--
Since deletion of both arginine-rich regions Rb
and Rc decreased IE4 homodimerization, amino acid substitutions were
introduced within either the bZIP domain situated at the amino-terminal
part of Rb, in Rb, in Rc, or in both Rb and Rc, or in the bZIP, Rb, and
Rc (Fig. 4). Substitution of arginine
residues with the bZIP sequence (amino acids 112-122) did not affect
dimerization (Fig. 4, pM4-bZIP). Substitution of individual arginine
residues by glycines within Rb or Rc did not modify either the
level of IE4 homodimerization (Fig. 4, pM4-Rb and
pM4-Rc). Finally, substitutions of all arginine residues in
Rb and Rc (Fig. 4, pM4-Rb + Rc) or within the bZIP sequence,
Rb and Rc (pM4-bZIP + Rb + Rc), only slightly affected LUC
activity, showing that IE4 homodimerization, in this system, depends
only on the integrity of both the central and carboxyl-terminal
regions.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Role of the arginine-rich regions Rb and Rc
in IE4 homodimerization. The schematic representation of IE4
protein is described in the legend to Fig. 2. The sequences of the
mutated Rb and Rc arginine-rich regions are represented with the
letters in boldface corresponding to the
substituted amino acids, as well as the three bZIP-like sequences that
are underlined. The transfection of HeLa cells and the LUC
activity were determined as described in the legend to Fig. 2.
|
|
Regions of IE4 Important for Dimerization Are Also Important for
Transactivation--
IE4 was shown to activate expression of VZV genes
as well as those of other viruses such as HIV-1 (2, 4, 11-14). In
order to clarify the mechanism of gene activation by IE4 on VZV
promoters and on heterologous promoters, we used transient transfection assays of HeLa cells with an IE4 expression plasmid (pC4) and a
reporter gene construct under the control of either the HIV-1 LTR
(pHIV-1-CAT) or the VZV TK promoter (pTK-CAT) (12, 26). IE4 expression
led to a dose-dependent increase in CAT activity under the
control of both promoters (data not shown) (12). Transfection of 2 µg
of pC4 gave rise to 15- and 7-fold increases in CAT expression under
the control of the HIV-1 LTR and VZV TK promoter, respectively (Fig.
5). In order to delineate regions of IE4
important for activation of either the VZV TK or HIV-1 promoter, base
deletion and base substitutions were introduced into the
IE4 gene. Deletion of amino acids 1-65 of the
amino-terminal region of IE4 (pC4-D-(1-65)) did not modify
transactivation of either reporter construct, demonstrating that this
acidic stretch was not required for gene activation. Removal of the
first arginine-rich region Ra (pC4-D-(66-110)) did not modify reporter
gene activation under the control of the HIV-1 LTR, whereas a slightly
decreased activation was observed with the VZV TK promoter (Fig. 5). On
the other hand, tandem deletion of arginine-rich regions Rb and Rc
(pC4-D-(111-181)) significantly reduced transactivation of the two
promoters. Interestingly, Rb turned out to be more important than Rc in
the activation of the two promoters. Individual deletion of Rb strongly
abolished gene activation by IE4 (pC4-D-(111-150)), whereas removal of
Rc (pC4-D-(150-182)) only had a partial effect on promoter
transactivation (Fig. 5). Base substitutions within these regions
revealed that the bZIP within Rb did not participate significantly in
gene activation, whereas mutations of the positively charged amino
acids within Rb lowered the efficiency of transactivation (Table
I). As we had previously observed with
the deletion mutants, the removal of the positive charges in Rc reduced
transactivation to a lesser extent than in Rb (Table I). These data
demonstrated that Rb and, to a lesser extent Rc, were involved in the
transactivating properties of IE4, whereas these regions appeared
dispensable for IE4 homodimerization.

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 5.
Regulatory properties of mutated IE4 proteins
on the VZV TK promoter (A) or the HIV-1 LTR
(B). HeLa cells were co-transfected with 0.5 µg
of pTK-CAT or 0.2 µg of pHIV-1-CAT and 2 µg of IE4 expression
vectors expressing either the wild-type or mutated IE4 proteins, as
indicated. CAT activities were determined 48 h post-transfection.
Fold stimulation of CAT activity was calculated relative to the basal
level of reporter plasmid in the presence of control plasmid alone
(pCDNA3.1 ), arbitrarily set to 1. The results shown
are representative of five independent experiments, and error
bars represent standard errors.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Transactivation properties of IE4 proteins modified in the
arginine-rich regions
The expression vectors used were derived from the plasmids described in
Fig. 4 and contain the same amino acid substitutions in the Rb and Rc
domains. Mutant IE4 proteins were tested as described in the legend to
Fig. 5. Means and S.D. were calculated from at least five independent
transfections.
|
|
As expected, the regions of IE4 that were involved in its dimerization
were required for gene activation. Each individual deletion of the
central part of IE4 abolished the reporter gene activation controlled
by the HIV-1 LTR or the VZV TK promoter (Fig. 5,
pC4-D-(183-390), -D-(182-231), -D-(266-302),
-D-(314-385)). Identical results were obtained when the
carboxyl-terminal region was removed (Fig. 5,
pC4-D-(394-452) and pC4-D-(444-452)). When substitutions were introduced into the carboxyl-terminal part of IE4,
they revealed the importance of cysteine 426 (Fig. 5, pC4-C426), as described previously (13, 29). As observed for dimerization, mutations within the GKYFKC peptide (pC4-G442, -K443, -Y444, -FK445, and -C447) strongly reduced transactivation, whereas mutations of the last five amino acids, STFNC, did not give to an
abolished gene activation process (Fig. 5, pC4-ST448,
-FN450, and -C452).
Arginine-rich Regions Rb and Rc Interact with Transcription Factor
IIB and p50--
It has been shown that VZV IE4 acts, at least, by
transcriptional activation and can interact with different components
of the basal transcription complex such as TBP and TFIIB as well as with p50 and p65 NF-
B subunit (29). To determine which regions of
IE4 are involved in these interactions, in vitro
protein-protein interaction experiments were made using a fusion
protein between GST and p50 or TFIIB coupled to glutathione-Sepharose
beads. A GST-TK fusion protein that carries VZV thymidine kinase was
purified according to the same procedure and used as a negative control in addition to GST alone. Equal amounts of in vitro
translated 35S-labeled IE4 or mutated IE4 were incubated
with GST-, GST-TK-, GST-p50-, or GST-TFIIB-coupled Sepharose beads.
After extensive washing, bound proteins were eluted and analyzed
by SDS-PAGE. Most of the IE4 specifically interacted with GST-p50 and
GST-TFIIB (Fig. 6), and there was no IE4
retained by the GST protein alone and the GST-TK-coupled Sepharose
beads (data not shown) as expected. Deletions into the central and
carboxyl-terminal parts of IE4 did not affect the interactions because
IE4-D-(182-231), -D-(266-302), -D-(314-385), and -D-(444-452) were
retained by GST-p50 and GST-TFIIB as efficiently as the IE4 protein
(Fig. 6) and not by GST and GST-TK (data not shown). In contrast, an
IE4 mutant protein that lacks the arginine-rich regions Rb and Rc,
IE4-D-(111-181), failed to interact with all GST-p50 and GST-TFIIB
fusion proteins (Fig. 6). Therefore, IE4 protein deleted individually
of Rb or Rc region were tested in the GST-pull-down assay. Each of the
in vitro translated IE4-D-(111-150) and IE4-D-(150-182)
proteins were found capable of binding to GST-p50 and GST-TFIIB with
similar affinity than IE4 (Fig. 6). Similar results were obtained with
IE4 mutant proteins containing base substitutions within these regions.
As shown in Fig. 6, substitution of arginine residues into the bZIP,
Rb, or Rc (IE4-bZIP, IE4-Rb, and IE4-Rc) did not significantly affect interaction with GST-p50 and GST-TFIIB, whereas mutations of the positively charged amino acids within Rb and Rc (IE4
Rb + Rc, IE4
bZIP + Rb + Rc) completely disrupted these properties.
These data demonstrated that Rb together with Rc, which were involved in the transactivating properties of IE4, are implicated in multiple protein-protein interactions with transcriptional factors such as p50
and TFIIB.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 6.
Role of the arginine-rich regions Rb and Rc
in their interactions with the transcription factor IIB and the
NF- B protein p50. Fusion proteins GST-p50
and GST-TFIIB, coupled to Sepharose beads, were incubated with in
vitro translated [35S]methionine-labeled IE4
wild-type and mutated as indicated at the top of each panel.
The beads were extensively washed in NETN and eluted in SDS sample
buffer before proteins were resolved on a 10% SDS-PAGE. Experiments
were repeated three times.
|
|
The Central and Carboxyl-terminal Domains Are Important for the
Cytoplasmic Localization of IE4--
In order to demonstrate that the
loss in gene activation observed with amino acid-substituted or
-deleted IE4 was not due to protein instability and to analyze the
intracellular localization of the mutated IE4 proteins,
immunofluorescence was carried out on HeLa cells transfected with the
various mutated constructs. As shown in Fig.
7A, transfection with pC4
revealed a classical distribution of IE4 (27), e.g. a
predominant distribution of the protein within the cytoplasm and a
mixed distribution within the cytoplasm and the nucleus. Deletion
within the amino-terminal part of the protein (amino acids 66-110),
including the acidic and Ra domains, did not modify IE4 localization
(data not shown). Deletions or base substitutions within the
arginine-rich domains Rb gave a predominant distribution of the protein
within the cytoplasm of transfected cells (Fig. 7B and data
not shown), whereas mutations into the Rc domain did not seem to affect
IE4 localization. Deletions within the central region of IE4 revealed
that all of the mutated IE4 proteins were preferentially localized
within the nucleus; a punctated nuclear distribution of IE4 was
even observed when amino acids 314-385 were deleted (Fig.
7C). A similar nuclear distribution was also observed with
deletion and several amino acid substitutions in the carboxyl-terminal
part of IE4. Individual mutations of the GKYFKC sequence led to a
nuclear distribution of the protein as observed in cells transfected
with pC4-D-(444-452) and pC4-Y444 (Fig. 7D and data not
shown), whereas mutations of amino acids 448-452 gave rise to both
nuclear and cytoplasmic forms of the molecule as observed with the
pC4-C452 expression vector.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 7.
Localization of wild-type and mutated IE4
proteins in HeLa cells. Cells were transfected with 2 µg of the
control vector pCDNA.3.1.- or the expression plasmids encoding IE4
wt (A), amino-terminal- (B), central-
(C), and (D) carboxyl-terminal-mutated IE4
proteins, as indicated on the panels, and reacted with a polyclonal
antibody raised against IE4 before immunofluorescence detection.
|
|
Because deletion of amino acids 427-452 gave rise to a nuclear
distribution of the mutated protein, we also introduced deletion of the
Rb or Rc domains together with deletion of amino acids 427-452 in
order to analyze whether these sequences were involved in nuclear
distribution of the protein. Immunofluorescence studies on cells
transfected with pC4-D-(111-150) -(427-452) or pC4-D-(150-182) -(427-452) exhibited a predominant nuclear localization, although more
cytoplasmic forms were observed in comparison with the pC4-D-(427-452) (Fig. 7D and data not shown), indicating that Rb and Rc
arginine regions only played a partial role in the nuclear localization of the protein. Similar observations were made when the arginine residues of the bZIP sequences were substituted tandemly with the
deletion of amino acids 444-452 (data not shown). These results demonstrated that the arginine residues of the bZIP-Rb-Rc region could
only be partially involved in the nuclear localization of IE4 or acted
only as a weak NLS.
Crm1 Is Involved in IE4 Nuclear Export--
Because IE4 was
predominantly found in the cytoplasm of transfected cells and some
mutated IE4 proteins were exclusively found in the nucleus, we analyzed
whether IE4 could utilize Crm1 as a cofactor for nuclear export. Some
RNA export proteins use the exportin Crm1, a
Ran-GTP-dependent transporter, to shuttle their cargo from
the nucleus to the cytoplasm (31). Recently, it has been shown that
ICP27 also mediated the export of some viral RNAs via a
Crm1-dependent pathway, whereas other viral mRNAs are
exported via another pathway (32). To determine whether nuclear export was indeed required for cytoplasmic localization of IE4, cells transfected by pC4 were treated with leptomycin B (LMB), a specific inhibitor of Crm1 that acts by blocking the formation of the
NES·Crm1·Ran-GTP complex. The localization of IE4 was then
analyzed by indirect immunofluorescence. Fig.
8A demonstrates that LMB
blocks the cytoplasmic accumulation of IE4. The distribution of
IE4-specific fluorescence was determined by counting
immunofluorescence-positive cells and ranking them in one of the
following categories: cells exhibiting exclusively nuclear or
cytoplasmic staining or cells exhibiting both nuclear and cytoplasmic
staining with cytoplasmic fluorescence either higher than, equal to, or
lower than the nuclear fluorescence. Without LMB treatment, IE4
staining was predominantly cytoplasmic or cytoplasmic and nuclear, with
staining in the nucleus weaker than in the cytoplasm (Fig.
8B) as described previously (27). After 6 h of
incubation in the presence of LMB, IE4 became predominantly nuclear or
simultaneously nuclear and cytoplasmic with nuclear staining greater
than or equal to the cytoplasmic staining (Fig. 8B). To
eliminate any new IE4 synthesis, cycloheximide was also included with
LMB, allowing us to monitor the movement of pre-existing protein. The
distribution of IE4 into transfected cells was similar to that observed
without cycloheximide (data not shown). The fact that cytoplasmic
retention of IE4 protein is partially disrupted by LMB suggests that
cytoplasmic localization of IE4 requires at least nuclear export
mediated by Crm1.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 8.
Shuttling of IE4 is partially mediated by the
Crm1-dependent nuclear export pathway. A,
HeLa cells were transfected with 2 µg of the expression plasmids
encoding IE4 wt (a and b), IE4-D-(111-181)
(c and d), IE4-D-(111-150) (e and
f), or IE4-D-(150-182) (g and h) as
indicated. 48 h post-transfection, cells were incubated with
(+ LMB) (b, d, f, and h) or without
( LMB) (a, c, e, and g) LMB for
6 h. Cells were then fixed, and the intracellular distribution of
IE4 was examined with an antibody specific for IE4 and a fluorescein
isothiocyanate-labeled secondary antibody. B, percentage of
IE4-positive cells in each localization pattern after transfection of
HeLa cells by pC4 treated (pC4 + LMB) or not (pC4 LMB) with LMB. Immunofluorescence-positive cells were counted
and categorized in one of five groups as follows: cells that exhibited
only cytoplasmic staining (C); cytoplasmic staining higher
(C>N), equal (C=N), or lower (N>C)
than nuclear staining; or nuclear staining only (N). The average
percentage of cells belonging to each category was calculated from
three independent transfection experiments, and error bars
represent standard errors.
|
|
Unexpectedly, LMB treatment did not alter the cytoplasmic localization
of the deleted proteins IE4-D-(111-181) and IE4-D-(111-150) (Fig.
8A). In contrast, exposure to LMB of cells transfected by pC4-D-(150-182) resulted in a shift in the distribution of the deleted
protein from a predominantly cytoplasmic to a nuclear localization as
observed with the IE4 protein (Fig. 8A). Similar results
were obtained with the substituted mutants into Rb or Rc regions; LMB
did not modify the cytoplasmic localization of the IE4-Rb protein,
whereas it partially blocked the IE4-Rc into the nucleus as observed
with the IE4 protein. These results confirm that IE4 mutated into the
Rb region was not blocked by LMB because it did not reach the nucleus
and that a nuclear localization signal is likely located into the Rb domain.
 |
DISCUSSION |
Despite structural similarities (15), VZV IE4 and HSV-1 ICP27
cannot complement each other (14, 33) and act differently in transient
transfection assays. IE4 transactivates a wide variety of target
constructs whether expressed alone or in synergy with VZV IE62 (2-4,
12, 13, 33). In contrast, ICP27 alone has little effect, if any, and
acts as a transrepressor or transactivator when co-transfected with
transcriptional activators such as ICP4 and ICP0 (19, 34-37). Studies
on ICP27 have shown that its expression is required for the switch from
early to late virus gene expression, lately they have highlighted the
multifunctional nature of this protein that acts both at the
transcriptional and post-transcriptional levels (reviewed in Ref. 38).
Although the molecular mechanisms underlying VZV IE4 regulatory
properties are still greatly misunderstood, the available data suggest
that IE4 could also exert its functions through transcriptional and
post-transcriptional mechanisms (11-13, 29). Based on amino acid
sequence homologies, different regions of VZV IE4 can be mapped as
follows: (i) an acidic region located at the amino-terminal part of the
protein; (ii) an arginine-rich region, also located near the amino
terminus, having limited amino acid homology with other herpesvirus
family members; (iii) a central region; and (iv) a zinc finger-like
sequence located close to the carboxyl terminus with the last two
regions sharing considerable amino acid conservation.
In the present study, we have attempted to dissect the functional
domains of the VZV IE4 protein that are important for gene activation.
By using the mammalian two-hybrid system, we found that VZV IE4 is
capable of homodimerization. We have shown that an intact
carboxyl-terminal cysteine-rich region as well as the central portion
of the protein are required for this interaction. Moreover, these two
regions seem involved in the correct intracellular localization of the
protein. Previous studies have demonstrated that IE4 may have several
mechanisms of action. Activation of VZV genes encoding the thymidine
kinase or IE62 seems to occur partly by a post-transcriptional
mechanism, whereas stimulation of a heterologous promoter such as HIV-1
LTR or the cytomegalovirus promoter seems to involve a transcriptional
mechanism (11, 13). In order to analyze the domains of the protein
implicated in these two mechanisms, we have tested the ability of a
variety of mutants to transactivate the VZV TK promoter and the HIV-1
LTR in transient expression experiments. We showed that the domains
turned out to be similar for stimulation of the two promoters and that,
in addition to the two regions needed for dimerization, the
arginine-rich region is also required.
The acidic region at the amino terminus of the protein is not essential
for dimerization or for transactivation of the two promoters as we
expected from our previous study, which demonstrated that this region
was not involved in dimerization nor in HIV-1 LTR transactivation (29).
This is in accordance with a previous report proposing that this region
was not required for activation of a reporter gene carrying an
efficient polyadenylation signal, whereas it was essential for
transactivation of a reporter gene carrying a minimal polyadenylation
signal (14). Our work also confirmed that the acidic amino-terminal
region was not involved in the proper addressing of the protein.
Although the amino-terminal regions of VZV IE4, HSV-1 ICP27 (14, 15),
equine herpesvirus 1 (EHV-1) UL3 (39), and their
-herpesvirus
homologs (40, 41) share little amino acid homology, they are all
acidic. In contrast to the acidic amino-terminal region of VZV IE4, the
corresponding region of ICP27 has previously been shown to be important
for trans-regulatory functions in transient expression assays (14, 42),
as well as for full viral replication (19, 42-44). Whereas these IE4
and ICP27 regions can functionally substitute for each other in
transient expression assays, the IE4 acidic region cannot efficiently
complement an HSV-1 mutant virus expressing ICP27 lacking this domain
(14). Recent data have revealed that ICP27 shuttles between the nucleus
and the cytoplasm at late times post-infection through a leucine-rich
nuclear export signal located between residues 7 and 15 (23, 25). It
should be pointed out that no similar sequence has been found in the
amino-terminal extremity of the IE4 protein.
Previous studies have shown that the basic domain located just next to
the acidic domain of VZV IE4 could be implicated in dimerization and
transactivation properties (14, 29). This domain has been divided into
three sequences rich in arginine residues called Ra, Rb, and Rc located
between amino acids 71-80, 112-143, and 164-179, respectively. Our
present data suggest that Ra, which has no counterpart in the ICP27
sequence, does not seem to play any role in transactivation nor in
dimerization, as previously shown (29). The Rb sequence does not appear
to be implicated in dimerization, whereas Rc may have a partial effect
in this property. Computer analysis has revealed the presence of three bZIP-like domains between residues 115 and 122 in the Rb region (29).
However, our results showed that these motives were not essential for
the dimerization of IE4, even though they have been shown to be
required for the dimerization of many transcription factors (45). On
the other hand, Rb and, to a lesser extent Rc, seem to be needed for a
full transactivation of the VZV TK promoter and the HIV-1 LTR. ICP27
also contains an arginine-rich domain that is divided into two
sequences called R1 and R2, which showed some similarities to the IE4
Rb sequence, and that was essential for the regulatory properties of
the HSV-1 protein (24). ICP27 is able to mediate export of viral
intronless mRNAs and to bind in vivo to RNA requiring
the R1 sequence, an arginine-glycine-rich region that resembles an RGG
box (23). Moreover, it was shown recently that ICP27 could interact
with two cellular proteins, the heterogenous nuclear ribonucleoprotein
K (hnRNP K) and the B subunit of casein kinase 2 (46). The ICP27 region
required for these interactions did not include the RGG box (R1) domain but the adjacent arginine-rich R2 sequence. Because the IE4 Rb sequence
seems to be essential for regulatory properties, we can postulate that
this sequence could be implicated in protein-protein interactions. This
hypothesis is also supported by a previous report showing that IE4
could interact with the TATA-binding protein and transcription factor
IIB of the basal complex of transcription as well as with the p50 and
p65 NF-
B subunits (29). The pull-down experiments presented above
confirm that the interactions with TFIIB and p50 could be mediated at
least by the arginine-rich domain encompassing the Rb and Rc domains.
Although protein-protein interactions through the arginine-rich domain
are not usual in gene regulation, it was recently demonstrated that
interactions between two proteins important in the outcome of Fanconi
anemia occurred in the cell nucleus through an unusual arginine-rich interaction domain (47).
The carboxyl-terminal region of VZV IE4 seems to be crucial for
dimerization, transactivation, and correct cellular localization as
shown with the various deletion mutants tested in this study. In
particular, substitutions within the carboxyl-terminal domain showed
that a GKYFKC peptide located between residues 442 and 447 was crucial
for dimerization and transactivation. Mutation of the Lys residue
(residue 504) in the homolog region in ICP27 led to the loss of
interaction with the small nuclear ribonucleoprotein particles (48),
demonstrating the role of this hexapeptide region in protein-protein
interactions. Although this carboxyl-terminal region of VZV IE4
contains cysteine and histidine residues, it is not known whether this
region binds zinc or whether it forms a potential zinc finger domain.
Recent studies have revealed that ICP27 self-associates in
vivo and that the carboxyl-terminal region beginning at residues
past 480 and extending to position 508 must be intact for
multimerization to occur, although the internal region encompassing
amino acids 288-444 may have partial effects on dimerization, as
demonstrated by co-immunoprecipitation assays (17).
In this study, we have unambiguously demonstrated that the central
region of VZV IE4 was also important for dimerization, as well as for
proper intracellular localization and gene activation. Reintroduction
of a irrelevant VZV sequence within the deleted VZV IE4
(pM4-D-(266-302)) gene did not allow recovery of efficient homodimerization (data not shown), demonstrating that the central region of IE4 was involved in the homodimerization process and that the
size of the deletion would not have affected the distance between
functional domains of VZV IE4. Recently, computer analysis of the
central and carboxyl-terminal sequences of ICP27 revealed three KH-like
RNA binding motifs, as well as an SM protein-protein interaction motif,
which are very well conserved among homologs from other
-herpesviruses (32). The KH motifs were first identified in the
human heterogeneous nuclear ribonucleoprotein (hnRNP) K protein as a
triple repeat (49). Mutations of the KH-like motifs into ICP27 resulted
in lethal phenotypes, and the authors (32) established that
substitution into the KH3 domain affected RNA binding in
vivo as well as nuclear export of ICP27. They proposed a model in
which KH1 and KH3 domains interact with each other. These interactions
could be important to form a structure that can interact with RNA, and
RNA binding could be a prerequisite for nuclear export of ICP27.
Alternatively, the KH domains might interact with other proteins, as
snRNPs (48) or casein kinase 2 (46). Moreover, the central region of
ICP27 (amino acids 179-406 encompassing KH1- and KH3-like motifs),
without the zinc finger-like domain, has also been directly implicated
in the interaction with ICP4, an essential regulatory protein of HSV-1
(50), confirming that this region could be implicated in multiple
protein-protein interactions. Deletions introduced into the central
part or the carboxyl terminus of IE4 overlap some potential KH-like
motifs. The various deletions introduced into IE4, i.e.
IE4-D-(182-231), IE4-D-(314-385), and IE4-D0(394-452), disrupt the
KH1-, KH2-, or KH3-like motifs localized between residues 181-258,
303-360, and 392-452, respectively (32). Therefore, it is obvious
that these motifs could play an essential role in the IE4 dimerization property as well as in the proper intracellular localization of the protein.
On the other hand, the proper localization of the IE4 protein seems to
be crucial for the regulatory properties because mutations into the Rb
regions gave rise to a cytoplasmic distribution of the mutated proteins
and mutations into the central and carboxyl-terminal parts also led to
a nuclear distribution, with a loss of the regulatory properties for
all of these mutants. We thus hypothesized that the regulatory
properties of IE4 could be mediated by the shuttling of the protein
between the cytoplasm and the nucleus. The fact that cytoplasmic
retention of IE4 protein is partially disrupted by LMB suggests that
cytoplasmic localization of IE4 requires at least nuclear export
mediated by Crm1, but another transport pathway cannot be excluded.
Protein trafficking into and out of the nucleus normally occurs through
direct interaction between a transport signal on the protein and the
transport receptors that mediated passage through the nuclear pore
complex. In many cases, nucleocytoplasmic shuttling is accomplished by
the combined actions of an NLS for import and a distinct NES for export
(for reviews see Refs. 51 and 52). The observation that the VZV IE4
deleted in either the central or the carboxyl-terminal regions was
localized into the nucleus argues that VZV IE4 could possess a nuclear
localization signal. This potential signal for nuclear localization
could be located within Rb region, since mutation within this domain
seemed to exclude the protein from the nucleus. Experiments with LMB
have confirmed that an NLS is located into the Rb domain because the
proteins mutated into the Rb region remains cytoplasmic even in the
presence of LMB. Classical NLSs consist usually of one or more clusters
of basic amino acids (51). Therefore, the sequence RKHRDRRSLSNRRRR into
the IE4 Rb domain could be a good candidate for NLS. Unexpectedly, only
partial relocalization of carboxyl-terminally truncated VZV IE4 within the cytoplasm was observed when the Rb region has been deleted, indicating that IE4 contains at least another nuclear localization signal. On the other hand, we cannot exclude the possibility that another mechanism of import exists for the nuclear mutated IE4 proteins. Because these mutants have also lost their dimerization property, we can postulate that they reach the nucleus by passive diffusion, as is the case for the mitogen-activated protein kinase, in
which dimeric and monomeric forms enter the nucleus by active transport
and passive diffusion mechanisms, respectively (53).
In this paper, we have shown that IE4 utilizes, at least, Crm1 as a
cofactor for nuclear export. Some proteins, especially some RNA export
proteins, use the exportin Crm1, a Ran-GTP-dependent transporter, to shuttle their cargo from the nucleus to the cytoplasm through a leucine-rich NES (31). Recently, it has been shown that ICP27
also mediated the export of some virus RNAs via a
Crm1-dependent pathway, whereas other virus mRNAs are
exported via another pathway (32). The shuttling of ICP27 between the
nucleus and the cytoplasm at late times post-infection occurs through a
leucine-rich NES located in the amino-terminal part (23, 25) but also
requires the central and carboxyl-terminal regions that have been
demonstrated to interact with RNA, a prerequisite for nuclear export
(32). No NES has been found in the amino-terminal part, but a putative sequence rich in leucine residues
(321LLENLKLKLG330) was found into the KH2-like
motif in the central part of the protein and could be correspond to an
NES. However, shuttling can also be controlled by an emerging class of
transport signals known as nucleocytoplasmic shuttling signals that can
direct both nuclear import and export (for review see Ref. 54). All
proteins currently known to contain this type of signal also associate with mRNA. An example of this is the hnRNP A1 protein that, by virtue of its M9 domain, is actively exported from the nucleus and
imported into the nucleus via a novel pathway mediated by the
transportin protein. The hnRNPK protein contains also a
nucleocytoplasmic shuttling signal of 24 residues, called KNS, in
addition to a classical bipartite-basic NLS (55). This signal is
localized between the KH2 and KH3 domains implicated in RNA-binding
activity described above. Moreover, KNS appears to mediate export via a Crm1-independent pathway (28). Curiously this sequence exhibits some
similarities with a sequence mapped between the KH2- and KH3-like
motifs found into IE4, which is very well conserved among
-herpesvirus homolog proteins. Particularly the tetrapeptide SADE is
perfectly conserved between KNS and IE4, and specific serines and
acidic residues seem to be necessary for the KNS activity (28). We can
thus postulate that IE4 also uses this type of newly described
nucleocytoplasmic shuttling signal that confers bi-directional
transport across the nuclear envelope and which is insensitive to LMB
treatment. On the other hand, because deletions into the central and
carboxyl-terminal parts of the protein affect the nuclear export, we
cannot exclude the possibility that RNA binding of IE4 could also be a
prerequisite for nuclear export, as is the case for ICP27. Moreover,
these mutations also affect the dimerization property of the protein,
allowing us to postulate that IE4 could bind RNA as a dimer before
being exported into the cytoplasm. Future work will be necessary to
confirm this hypothesis and also to test the RNA binding property of IE4.
VZV IE4 has been shown to be a multifunctional protein. Here, we have
presented strong biochemical evidence demonstrating that IE4
self-associates in vivo and that IE4 homodimerization mainly
occurs through the central and the carboxyl-terminal regions beginning
at residues past 182 and extending to position 447. Amino acid
substitution within the carboxyl-terminal domain showed that a GKYFKC
peptide was crucial for self-interaction. Regions of IE4 important for
dimerization were also shown to be crucial for transactivation and for
proper intracellular localization of IE4. In addition, the
arginine-rich domains Rb and, to a lesser extent, Rc were also
demonstrated to be important for transactivation but not for
homodimerization, whereas the amino-terminal sequence encompassing the
acidic sequence, the first arginine-rich domain Ra, and the bZIP-like
sequences were shown to be dispensable for gene transactivation. A
Crm1-dependent nuclear export mechanism has also been shown
to be important for the cellular localization of IE4.
 |
ACKNOWLEDGEMENTS |
We thank U. Siebenlist (National Institutes
of Health, Bethesda), E. Verdin (Gladstone Institute, San Francisco),
and M. Müller (University of Liege) for providing plasmids.
 |
FOOTNOTES |
*
This work was supported in part by grants from the Belgian
National Fund for Scientific Research (Brussels, Belgium), the VZV
Research Foundation (New York), and the "Concerted Action Program"
(Communauté Française de Belgique, Brussels, Belgium).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a Belgian National Fund for Scientific Research
Scientific Collaborator grant.
§
Funded by the Belgian National Fund for Scientific Research and a
VZV Research Foundation Fellowship.
¶
Research Director at the Belgian National Fund for Scientific
Research. To whom correspondence should be addressed: Laboratory of
Fundamental Virology and Immunology, Institute of Pathology B23,
University of Liege, B-4000 Liege, Belgium. Tel.: 32-4-366-24-42; Fax:
32-4-366-24-33; E-mail: jpiette@ulg.ac.be.
Published, JBC Papers in Press, July 10, 2000, DOI 10.1074/jbc.M001444200
 |
ABBREVIATIONS |
The abbreviations used are:
VZV, varicella-zoster virus;
HSV-1, herpes simplex virus, type 1;
NLS, nuclear localization signals;
LUC, luciferase;
PCR, polymerase chain
reaction;
GST, glutathione S-transferase;
CAT, chloramphenicol acetyltransferase;
LTR, long terminal repeat;
PAGE, polyacrylamide gel electrophoresis;
wt, wild type;
NES, nuclear export
signal;
hnRNP, heterogeneous nuclear ribonucleoprotein;
LMB, leptomycin
B;
HIV-1, human immunodeficiency virus, type 1;
TK, thymidine
kinase;
TBP, TATA-binding protein.
 |
REFERENCES |
| 1.
|
Honess, R. W.,
and Roizman, B.
(1974)
J. Virol.
14,
8-19
|
| 2.
|
Inchauspe, G.,
Nagpal, S.,
and Ostrove, J. M.
(1989)
Virology
173,
700-709
|
| 3.
|
Nagpal, S.,
and Ostrove, J. M.
(1991)
J. Virol.
65,
5289-5296
|
| 4.
|
Perera, L. P.,
Mosca, J. D.,
Ruyechan, W. T.,
and Hay, J.
(1992)
J. Virol.
66,
5298-5304
|
| 5.
|
Moriuchi, H.,
Moriuchi, M.,
Straus, S. E.,
and Cohen, J. I.
(1993)
J. Virol.
67,
2739-2746
|
| 6.
|
Moriuchi, H.,
Moriuchi, M.,
Straus, S. E.,
and Cohen, J. I.
(1993)
J. Virol.
67,
4290-4295
|
| 7.
|
Baudoux, L.,
Defechereux, P.,
Schoonbroodt, S.,
Merville, M.-P.,
Rentier, B.,
and Piette, J.
(1995)
Nucleic Acids Res.
23,
1341-1349
|
| 8.
|
Hay, I.,
and Ruyechan, W. T.
(1994)
Semin. Virol.
5,
241-248
|
| 9.
|
Forghani, B.,
Mahalingham, R.,
Vafai, A.,
Hurst, J. W.,
and Dupuis, K. W.
(1990)
Virus Res.
16,
195-210
|
| 10.
|
Debrus, S.,
Sadzot-Delvaux, C.,
Nikkels, A.,
Piette, J.,
and Rentier, B.
(1995)
J. Virol.
69,
3240-3245
|
| 11.
|
Defechereux, P.,
Debrus, S.,
Baudoux, L.,
Rentier, B.,
and Piette, J.
(1997)
J. Virol.
71,
7073-7079
|
| 12.
|
Defechereux, P.,
Melen, L.,
Baudoux, L.,
Merville-Louis, M.-P.,
Rentier, B.,
and Piette, J.
(1993)
J. Virol.
67,
4379-4385
|
| 13.
|
Perera, L. P.,
Kaushal, S.,
Kinchington, P. R.,
Mosca, J. D.,
Hayward, G. S.,
and Straus, S. E.
(1994)
J. Virol.
68,
2468-2477
|
| 14.
|
Moriuchi, H.,
Moriuchi, M.,
Debrus, S.,
Piette, J.,
and Cohen, J. I.
(1995)
Virology
208,
376-382
|
| 15.
|
Davison, A. J.,
and Scott, J. E.
(1986)
J. Gen. Virol.
67,
1759-1816
|
| 16.
|
Connaway, R. C.,
and Connaway, J. W.
(1993)
Annu. Rev. Biochem.
62,
161-190
|
| 17.
|
Zhi, Y.,
Sciabica, K. S.,
and Sandri-Goldin, R. M.
(1999)
Virology
257,
341-351
|
| 18.
|
Smith, I. L.,
Sekulovich, R. E.,
Hardwicke, M. A.,
and Sandri-Goldin, R. M.
(1991)
J. Virol.
65,
3656-3666
|
| 19.
|
Hardwicke, M. A.,
Vaughan, P. J.,
Sekulovich, R. E.,
O'Conner, R.,
and Sandri-Goldin, R. M.
(1989)
J. Virol.
63,
4590-4602
|
| 20.
|
Courey, A. J.,
and Tijan, R.
(1988)
Cell
55,
887-898
|
| 21.
|
Mears, W. E.,
and Rice, S. A.
(1996)
J. Virol.
70,
7445-7453
|
| 22.
|
Mears, W. E.,
Lam, V.,
and Rice, S. A.
(1995)
J. Virol.
69,
935-947
|
| 23.
|
Sandri-Goldin, R. M.
(1998)
Genes Dev.
12,
868-879
|
| 24.
|
Hibbard, M. K.,
and Sandri-Goldin, R. M.
(1995)
J. Virol.
69,
4656-4667
|
| 25.
|
Soliman, T. M.,
Sandri-Goldin, R. M.,
and Silverstein, S.
(1997)
J. Virol.
71,
9188-9197
|
| 26.
|
Gendelman, H. E.,
Phelps, W.,
Feigenbaum, L.,
Ostrove, J. M.,
Adachi, A.,
Howley, P. M.,
Koury, J.,
Ginsberg, H. S.,
and Martin, M. A.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
9759-9763
|
| 27.
|
Defechereux, P.,
Debrus, S.,
Baudoux, L.,
Schoonbroodt, S.,
Merville, M.-P.,
Rentier, B.,
and Piette, J.
(1996)
J. Gen. Virol.
77,
1505-1513
|
| 28.
|
Henderson, B. R.,
and Eleftheriou, A.
(2000)
Exp. Cell Res.
256,
213-224
|
| 29.
|
Defechereux-Thibaut de Maisière, P.,
Baudoux-Tebache, L.,
Merville, M.-P.,
Rentier, B.,
Bours, V.,
and Piette, J.
(1998)
J. Biol. Chem.
273,
13636-13644
|
| 30.
|
Dang, C. V.,
Barrett, J.,
Villa-Garcia, M.,
Resar, L. M.,
Kato, G. J.,
and Fearon, E. R.
(1991)
Mol. Cell. Biol.
11,
954-962
|
| 31.
|
Ullman, K. S.,
Powers, M. A.,
and Forbes, D. J.
(1997)
Cell
90,
1041-1050
|
| 32.
|
Soliman, T. M.,
and Silverstein, S. J.
(2000)
J. Virol.
74,
2814-2825
|
| 33.
|
Moriuchi, H.,
Moriuchi, M.,
Smith, H. A.,
and Cohen, J. I.
(1994)
J. Virol.
68,
1987-1992
|
| 34.
|
Sekulovich, R. E.,
Leary, K.,
and Sandri-Goldin, R. M.
(1988)
J. Virol.
62,
4510-4522
|
| 35.
|
Su, L.,
and Knipe, D. M.
(1989)
Virology
170,
496-504
|
| 36.
|
Everett, R. D.
(1986)
J. Gen. Virol.
68,
2507-2513
|
| 37.
|
Rice, S. A.,
and Knipe, D. M.
(1988)
J. Virol.
62,
3814-3823
|
| 38.
|
Pheland, A.,
and Clements, J. B.
(1998)
Semin. Virol.
8,
309-318
|
| 39.
|
Smith, R. H.,
Zhaho, Y.,
and O'Callaghan.
(1993)
J. Virol.
67,
1105-1109
|
| 40.
|
Chevalier-Greco, A.,
Manet, E.,
Chavrier, P.,
Mosnier, C.,
Daillie, J.,
and Sergeant, A.
(1986)
EMBO J.
5,
3243-3249
|
| 41.
|
Nicholas, J.,
Gombels, U. A.,
Craxton, M. A.,
and Honess, R. W.
(1988)
J. Virol.
62,
5298-5304
|
| 42.
|
Rice, S. A.,
Lam, V.,
and Knipe, D. M.
(1993)
J. Virol.
67,
1778-1787
|
| 43.
|
McMahan, L.,
and Schaffer, P. A.
(1990)
J. Virol.
64,
3471-3485
|
| 44.
|
Rice, S. A.,
and Knipe, D. M.
(1990)
J. Virol.
64,
1704-1715
|
| 45.
|
Ellenberger, T.
(1994)
Curr. Opin. Struct. Biol.
4,
12-21
|
| 46.
|
Wadd, S.,
Bryan, H.,
Filhol, O.,
Scott, J. E.,
Hsieh, T.-Y.,
Everett, R. D.,
and Clements, J. B.
(1999)
J. Biol. Chem.
274,
28991-28998
|
| 47.
|
Kruyt, F. A.,
Abou-Zhar, F.,
Mok, H.,
and Youssoufian, H.
(1999)
J. Biol. Chem.
274,
34212-34218
|
| 48.
|
Sandri-Goldin, R. M.,
and Hibbard, M. K.
(1996)
J. Virol.
70,
108-118
|
| 49.
|
Siomi, H.,
Matunis, M. J.,
Michael, W. M.,
and Dreyfuss, G.
(1993)
Nucleic Acids Res.
21,
1193-1198
|
| 50.
|
Panagiotidis, C. A.,
Lium, E. K.,
and Silverstein, S. J.
(1997)
J. Virol.
71,
1547-1557
|
| 51.
|
Dingwall, C.,
and Laskey, R. A.
(1991)
Trends Biochem. Sci.
16,
478-481
|
| 52.
|
Hood, J. K.,
and Silver, P. A.
(1999)
Curr. Opin. Cell Biol.
11,
241-247
|
| 53.
|
Adashi, M.,
Fukuda, M.,
and Nishida, E.
(1999)
EMBO J.
18,
5347-5358
|
| 54.
|
Michael, W. M.
(2000)
Trends Cell Biol.
10,
46-50
|
| 55.
|
Michael, W. M.,
Eder, P. S.,
and Dreyfuss, G.
(1997)
EMBO J.
16,
3587-3598
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.